Needham Maintains Buy on WalkMe, Lowers Price Target to $20
Needham analyst Scott Berg maintains WalkMe (NASDAQ:WKME) with a Buy and lowers the price target from $40 to $20.
Keybanc Downgrades WalkMe to Sector Weight
Keybanc analyst Michael Turits downgrades WalkMe (NASDAQ:WKME) from Overweight to Sector Weight.
WalkMe Reports Collab With Celonis ‘to Optimize Business Performance for Customers,’ No Terms Disclosed
Combining WalkMe's and Celonis' best-in-class solutions allows customers to identify and fix process inefficiencies directly in their day-to-day applications, improving cash flow, operating margins, and user
WalkMe Q1 Sales $56.80M Beat $56.10M Estimate
WalkMe (NASDAQ:WKME) reported quarterly sales of $56.80 million which beat the analyst consensus estimate of $56.10 million by 1.25 percent.
Keybanc Maintains Overweight on WalkMe, Lowers Price Target to $20
Keybanc maintains WalkMe (NASDAQ:WKME) with a Overweight and lowers the price target from $23 to $20.
Where WalkMe Stands With Analysts
WalkMe (NASDAQ:WKME) has observed the following analyst ratings within the last quarter:
42 Stocks Moving In Friday’s Mid-Day Session
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 72.6% to $6.56 after jumping 17% on Thursday.
60 Biggest Movers From Yesterday
Gainers
Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer Ventures.